Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/21/2013 | US20130046079 Mouse lambda light chain locus |
02/21/2013 | US20130045923 Collagenous material |
02/21/2013 | US20130045888 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris |
02/21/2013 | US20130045506 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
02/21/2013 | US20130045505 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
02/21/2013 | US20130045492 Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
02/21/2013 | US20130045482 Bacteria and the uses thereof |
02/21/2013 | US20130045305 Yeast extract containing gamma-glu-x or gamma-glu-x-gly and a method for producing the same |
02/21/2013 | US20130045231 Immunogenic composition |
02/21/2013 | US20130045219 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
02/21/2013 | US20130045209 WNT-Binding Agents and Uses Thereof |
02/21/2013 | US20130045205 Methods and Compositions Related to Glycoprotein-Immunoglobulin Fusions |
02/21/2013 | US20130045191 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
02/21/2013 | CA2844674A1 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
02/20/2013 | EP2559762A1 Novel anti-hsp90 monoclonal antibody |
02/20/2013 | EP2558591A1 Method for the selection of a long-term producing cell |
02/20/2013 | EP2558588A2 A YEAST EXTRACT CONTAINING y-Glu-X OR y-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME |
02/20/2013 | EP2558587A2 Method for displaying antibodies |
02/20/2013 | EP2492344A9 Rapid display method in translational synthesis of peptide |
02/20/2013 | CN102939376A Novel cellulase gene |
02/20/2013 | CN102936612A Method for preparing anti-canine distemper virus monoclonal antibody by adopting bioreactor |
02/20/2013 | CN102936611A Collagen extracted from black butterflyfish skins with scales and application of collagen |
02/20/2013 | CN102936610A Method for highly efficiently extracting protein from walnut dreg |
02/20/2013 | CN102936609A Preparation method of swift moth paecilomyces varioti extracellular acid glycoprotein |
02/20/2013 | CN102935224A Medicinal extract ointment for treating skin scald |
02/19/2013 | US8378087 Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
02/19/2013 | US8378081 Antibodies that specifically bind to Aβ oligomers and uses thereof |
02/19/2013 | US8378080 Neuropilin antagonists |
02/19/2013 | US8378078 Diagnosis of Whipple's disease |
02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
02/19/2013 | US8377674 Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity |
02/19/2013 | US8377671 [NiFe]-hydrogenases having an improved resistance to dioxygen, process for obtaining them and their applications |
02/19/2013 | US8377670 Laccases for bio-bleaching |
02/19/2013 | US8377667 Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-CoA, putrescine and related compounds, and methods related thereto |
02/19/2013 | US8377666 Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto |
02/19/2013 | US8377659 Variant Humicola grisea CBH1.1 |
02/19/2013 | US8377654 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
02/19/2013 | US8377652 Production of long chain unbranched beta-poly(L-malic acid) by large scale Physarum cultivation and high-grade purification of the same |
02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
02/19/2013 | US8377439 Antagonist antibodies against EPHB3 |
02/19/2013 | US8377435 Antibody induced cell membrane wounding |
02/19/2013 | CA2594151C Methods for the production and secretion of modified peptides |
02/19/2013 | CA2587494C Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
02/19/2013 | CA2480319C Chimeric delta endotoxin protein of cry1ea and cry1ca |
02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
02/19/2013 | CA2467048C Method of protein purification |
02/19/2013 | CA2426698C Method for producing proteins by electroporation |
02/14/2013 | WO2013023137A2 Multi-hierarchical self-assembly of a collagen mimetic peptide |
02/14/2013 | WO2013022083A1 Novel anti-human ngf antibody |
02/14/2013 | WO2012169940A9 Recombinant dna elements for the expression of recombinant proteins in insects |
02/14/2013 | WO2012169939A9 Recombinant dna elements for the expression of recombinant proteins in a host cell |
02/14/2013 | US20130041044 Phase separated composite |
02/14/2013 | US20130040897 Glycosylation of proteins in host cells |
02/14/2013 | US20130040889 Factor VIII Fusion Protein |
02/14/2013 | US20130040391 Method for manufacturing glycoproteins having human-type glycosylation |
02/14/2013 | US20130039938 Highly efficient influenza matrix (m1) proteins |
02/14/2013 | US20130039926 Human antibodies against rabies and uses thereof |
02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
02/14/2013 | US20130039913 Heterodimeric antibody fc-containing proteins and methods for production thereof |
02/14/2013 | US20130039889 Recombinant microorganisms |
02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
02/14/2013 | CA2843640A1 N-glycosylated insulin analogues |
02/14/2013 | CA2841181A1 Novel anti-human ngf antibody |
02/13/2013 | EP2557157A1 Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
02/13/2013 | EP2556163A1 High mannose glycans |
02/13/2013 | CN102933231A Cd20 antibodies and uses thereof |
02/13/2013 | CN102925524A Seafood leftover oligopeptide and preparation method thereof |
02/13/2013 | CN102925523A Enzyme hydrolysis method for preparing fetus cervi active peptide |
02/13/2013 | CN102925522A Method for preparing pilose antler peptide dry powder by enzymolysis method |
02/13/2013 | CN102925521A Soybean peptide capable of shortening ultrahigh-concentration beer fermentation period, preparation method and application thereof |
02/13/2013 | CN102925520A Method for producing laver antihypertensive peptides |
02/13/2013 | CN102925519A Preparation process of recombinant hepatic targeting interferon |
02/13/2013 | CN102925403A Recombinant strain capable of expressing fungal immunomodulatory protein from Flammulina velutipes (FIP-fve), construction method, protein expression and purification method, and protein application |
02/13/2013 | CN102924605A TELKP and LKP fusion immunotoxin and prokaryotic expression vector and preparation thereof |
02/13/2013 | CN102924585A Neublastin variants |
02/13/2013 | CN102924584A Recombinant lubricin molecules and uses thereof |
02/13/2013 | CN102920992A Injection recombinant follistatin preparation and preparation method |
02/13/2013 | CN102127552B CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI |
02/13/2013 | CN101948897B Method for extracting shinyleaf yellowhorn oil, shinyleaf yellowhorn polysaccharide and shinyleaf yellowhorn protolysate peptide from shinyleaf yellowhorn |
02/13/2013 | CN101693742B Anti-IGF-I receptor antibody |
02/13/2013 | CN101608202B Preparation method of antihypertensive peptide |
02/13/2013 | CN101573444B Lytic enzyme inhibitor, lysis inhibitor, inhibitor of degradation of poly-gamma-glutamic acid, and method for production of poly-gamma-glutamic acid |
02/13/2013 | CN101213297B Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
02/12/2013 | US8372989 Contacting a polypeptide with tryptophan or 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid to facilitate a conversion of tryptophan to indole-3-pyruvate, a conversion of 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid to 2-Hydroxy-2-(indol-3-ylmethyl)-4-aminoglutaric acid (monatin) |
02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
02/12/2013 | US8372961 Polynucleotides encoding concatameric immunoadhesion molecules |
02/12/2013 | US8372958 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
02/12/2013 | US8372625 Polynucleotides encoding antagonist antibodies against GDF-8 |
02/12/2013 | US8372620 Using fungal xylanase to prepare dough which is less sticky; food processing; food treatment; enzyme inhibitors |
02/12/2013 | US8372608 Processes for making [R]-ethyl 4-cyano-3 hydroxybutyric acid |
02/12/2013 | US8372602 Methods for producing cytokine receptor ZALPHA11 |
02/12/2013 | US8372598 Salt selection of microbial mutants to increase bioproduct tolerance, titer, or osmotic shock tolerance |
02/12/2013 | US8372404 Anti-C5/C5a antibodies and methods of use |
02/12/2013 | US8372401 Human antibodies that bind human TNFα |
02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
02/12/2013 | US8372399 Bispecific antibodies and agents to enhance stem cell homing |
02/12/2013 | CA2587712C Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant |
02/12/2013 | CA2469715C Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |